185 related articles for article (PubMed ID: 32606658)
1. Eudragit
El-Maghawry E; Tadros MI; Elkheshen SA; Abd-Elbary A
Int J Nanomedicine; 2020; 15():3965-3980. PubMed ID: 32606658
[TBL] [Abstract][Full Text] [Related]
2. Dual Functional Eudragit
Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M
Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
[TBL] [Abstract][Full Text] [Related]
3. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
4. Development, Characterization, and Investigation of In Vivo Targeted Delivery Efficacy of Luteolin-Loaded, Eudragit S100-Coated mPEG-PLGA Nanoparticles.
Liu X; Zhang M; Tian Y; Liu R; Wang Y; Guo F; Gong Y; Yan M
AAPS PharmSciTech; 2022 Mar; 23(4):100. PubMed ID: 35348949
[TBL] [Abstract][Full Text] [Related]
5. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
[TBL] [Abstract][Full Text] [Related]
6. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
Ghorab DM; Amin MM; Khowessah OM; Tadros MI
Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease.
Zeeshan M; Ali H; Khan S; Mukhtar M; Khan MI; Arshad M
Nanomedicine (Lond); 2019 Aug; 14(15):1945-1969. PubMed ID: 31355705
[No Abstract] [Full Text] [Related]
8. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
10. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats.
Anwer MK; Mohammad M; Ezzeldin E; Fatima F; Alalaiwe A; Iqbal M
Int J Nanomedicine; 2019; 14():1587-1595. PubMed ID: 30880967
[TBL] [Abstract][Full Text] [Related]
11. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ
Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695
[TBL] [Abstract][Full Text] [Related]
12. Preparation of ultrafine poly(methyl methacrylate-co-methacrylic acid) biodegradable nanoparticles loaded with ibuprofen.
Saade H; Diaz de León-Gómez R; Enríquez-Medrano FJ; López RG
J Biomater Sci Polym Ed; 2016 Aug; 27(11):1126-38. PubMed ID: 27126476
[TBL] [Abstract][Full Text] [Related]
13. Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity.
Alper Öztürk A; Namlı İ; Aygül A
Assay Drug Dev Technol; 2021 Apr; 19(3):156-175. PubMed ID: 33728979
[No Abstract] [Full Text] [Related]
14. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
15. Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles.
Naha PC; Kanchan V; Manna PK; Panda AK
J Microencapsul; 2008 Jun; 25(4):248-56. PubMed ID: 18465311
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles encapsulated in methacrylate coated gelatin with sustained release for specific medical applications.
Akhavan Farid E; Davachi SM; Pezeshki-Modaress M; Taranejoo S; Seyfi J; Hejazi I; Tabatabaei Hakim M; Najafi F; D'Amico C; Abbaspourrad A
J Biomater Sci Polym Ed; 2020 May; 31(7):910-937. PubMed ID: 32009574
[TBL] [Abstract][Full Text] [Related]
17. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.
Cetin M; Atila A; Kadioglu Y
AAPS PharmSciTech; 2010 Sep; 11(3):1250-6. PubMed ID: 20697984
[TBL] [Abstract][Full Text] [Related]
19. PEG-PLGA- hybrid nanoparticles loaded with etoricoxib - phospholipid complex for effective treatment of inflammation in rat model.
Dave V; Srivastava P; Tak K; Sharma S
J Microencapsul; 2019 May; 36(3):236-249. PubMed ID: 31092089
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
Yehia SA; Elshafeey AH; Elsayed I
Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
